Amdocs Limited
DOX · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $4,533 | $5,005 | $4,888 | $4,577 |
| % Growth | -9.4% | 2.4% | 6.8% | – |
| Cost of Goods Sold | $2,875 | $3,250 | $3,160 | $2,958 |
| Gross Profit | $1,658 | $1,755 | $1,728 | $1,619 |
| % Margin | 36.6% | 35.1% | 35.3% | 35.4% |
| R&D Expenses | $341 | $361 | $375 | $355 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $494 | $573 | $571 | $529 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $193 | $128 | $71 |
| Operating Expenses | $835 | $1,127 | $1,074 | $954 |
| Operating Income | $823 | $629 | $654 | $665 |
| % Margin | 18.2% | 12.6% | 13.4% | 14.5% |
| Other Income/Exp. Net | -$130 | -$38 | -$18 | -$16 |
| Pre-Tax Income | $693 | $591 | $636 | $648 |
| Tax Expense | $125 | $95 | $93 | $99 |
| Net Income | $568 | $493 | $541 | $550 |
| % Margin | 12.5% | 9.9% | 11.1% | 12% |
| EPS | 5.08 | 4.27 | 4.52 | 4.47 |
| % Growth | 19% | -5.5% | 1.1% | – |
| EPS Diluted | 5.05 | 4.25 | 4.49 | 4.44 |
| Weighted Avg Shares Out | 111 | 113 | 118 | 121 |
| Weighted Avg Shares Out Dil | 112 | 114 | 118 | 122 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $17 | $21 | $8 |
| Interest Expense | $38 | $35 | $23 | $17 |
| Depreciation & Amortization | $195 | $193 | $196 | $225 |
| EBITDA | $927 | $819 | $855 | $890 |
| % Margin | 20.5% | 16.4% | 17.5% | 19.4% |